Categories
-
Adhesives
6
Amines
101
Amino Acids
185
Analytical Reagents
714
Antibiotics
255
Bioactive Small Molecules
742
Aroma Chemicals
213
Biochemicals
1051
Boronic Acids
4
Buffers
98
Building Blocks
1928
Carbohydrates
180
Catalysts
111
Chiral Compounds
59
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
262
Flavours and Fragrance Materials
214
Fluorinated Products
51
Furans
6
Gases in Solution
49
Grignard Reagents
26
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
345
Ion-Pair Reagents
24
Ligands
80
Organics
1440
Oxazoles
3
Peptide Reagents
91
Phenols
50
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
57
Pyrimidines
31
Quaternary Ammonium salts
43
Reagents
108
Research Organics & Inorganics
804
Salts
299
Sealing Compounds
1
Sherclin
1
Solvents
127
Stains & Indicators
305
Sugars
64
Tailor-made solutions
1
Testing Standards
4
Uncategorised
30
Water Analysis
13
Oxcarbazepine
(31059093 | 28721-07-5)
CAS: | 28721-07-5 |
---|---|
Molecular Formula: | C15H12N2O2 |
Molecular Weight: | 252.27 |
Availablility: | In Stock |
---|---|
Downloads: | | |
31059093-1g | 1g | £30.90 | |
31059093-5g | 5g | £93.50 | |
Bulk Order |
31059093-1g | 1g | €43.30 | |
31059093-5g | 5g | €130.90 | |
Bulk Order |
31059093-1g | 1g | $46.40 | |
31059093-5g | 5g | $140.30 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 31059093 | ||||
Product Name | Oxcarbazepine | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 28721-07-5 | ||||
Molecular Formula | C15H12N2O2 | ||||
Molecular Weight | 252.27 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 2933998090 |
Product Specification
Melting Point | 222 - 228°C | ||||
Loss on Drying | ≤0.3% | ||||
Assay | ≥99% | ||||
Residue on Ignition | ≤0.2% | ||||
Total Impurities | ≤1.0% | ||||
Appearance | Off white/ pale orange powder | ||||
Total Unknown Impurities | ≤0.5% | ||||
Carbamazepine | ≤0.2% |
Safety Information
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|